Anzeige
Mehr »
Sonntag, 08.02.2026 - Börsentäglich über 12.000 News
Der Shakeout: Silber hat genau das getan, was echte Bullenmärkte immer tun - es hat die Touristen abgeschüttelt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
297 Leser
Artikel bewerten:
(1)

Time To Stimulate, Not Limit, Pediatric Subspecialist Training

Federal budget cuts threaten training program necessary to fill growing specialist gap, meet increasing patient need

BOSTON, May 2, 2011 /PRNewswire-USNewswire/ -- As Washington looks for ways to trim budget costs, one of the programs facing continued threats of cuts or elimination is the Children's Hospitals Graduate Medical Education (CHGME) Program, a program administered by the Health Resources and Services Administration (HRSA) that provides federal funds to freestanding children's hospitals to support pediatrician and resident training. A new commentary in the May Archives of Pediatrics & Adolescent Medicine illustrates the critical need for continued funding of this vital program, which supports the training of more than 40 percent of all pediatricians and 43 percent of all pediatric subspecialists.

Written by Dennis Rosen, MD, a pediatric pulmonologist at Children's Hospital Boston, the article describes a concerning trend in pediatrics that CHGME plays a crucial role in addressing. Across the nation there is a growing shortage of pediatric subspecialists. Fewer pediatric residency graduates are pursuing subspecialty training, creating significant vacancies nationwide in fields such as pediatric rheumatology, nephrology, and pulmonology, among others. The causes of this vary, and may include lifestyle choices and personal/financial issues (large burdens of debt, non-competitive salaries). As the current pool of subspecialists age toward retirement, substantial gaps in the ability of health care institutions to provide care and a greater inability to meet increasing demand are developing.

"Access to pediatric subspecialty care varies significantly across the country, with some states already lacking subspecialists in fields such as pediatric pulmonology and critical care," says Rosen. "The trends we see now are very worrisome, and without intervention we can expect to see increasing shortages in almost every area of pediatric subspecialty medicine. This will have severe implication for the health of those children in need of specialty care, such as those with diabetes, asthma, or developmental delay, affecting their quality of life as well as that of their families, and ultimately lead to increases in health care costs."

The CHGME program has proven to be successful in addressing a diminished pediatric specialist workforce by helping to fund pediatric training programs. Prior to its enactment in 2000 there was a decline in the numbers of both general pediatricians and pediatric subspecialists. Following its enactment, the decline was reversed.

While the number of primary care pediatricians has increased in recent years, it has not increased at the rate needed to keep up with demand. This further underscores the importance of sustaining CHGME in order to help children's hospitals attract and educate the next generation of pediatric care providers.

"We've seen the positive impact of CHGME, and sustaining this program is one of many interventions needed to ensure provision of high quality health care to the children of this country in the years to come," says Rosen. "We're already seeing the effects of the declining pediatric workforce. At Children's, we see patients who need to travel great distances for treatment because they have no access to the care they need in their home states. If current trends are not reversed, the situation will get dramatically worse."

CHGME is due for reauthorization this year, and is expected to be filed in the coming weeks. While authorized through September 2011, short and longer term funding for CHGME is in jeopardy.There is a significant reduction in funds available for HRSA through the end of FY2011, as part of the agreement made to avoid a federal government shutdown, and President Obama's budget proposal for FY2012 would eliminate the program.

Founded in 1869 as a 20-bed hospital for children, Children's Hospital Boston today is one of the nation's leading pediatric medical centers, the primary pediatric teaching hospital of Harvard Medical School, and the largest provider of health care to Massachusetts children. In addition to 395 pediatric and adolescent inpatient beds and more than 100 outpatient programs, Children's houses the world's largest research enterprise based at a pediatric medical center, where its discoveries benefit both children and adults. More than 1,100 scientists, including nine members of the National Academy of Sciences, 12 members of the Institute of Medicine and 13 members of the Howard Hughes Medical Institute comprise Children's research community. For more information about the hospital visit: www.childrenshospital.org/newsroom.

CONTACT:
Keri Stedman
Children's Hospital Boston
617-919-3110
keri.stedman@childrens.harvard.edu

SOURCE Children's Hospital Boston

© 2011 PR Newswire
Vorsicht, geheim!
2026 startet mit einem Paukenschlag: Der DAX outperformt den US-Markt, Nachzügler holen auf. Ein erstes Signal, dass der Bullenmarkt an Breite gewinnt. Während viele Anleger weiter auf die großen Tech-Namen setzen, hat sich im Hintergrund längst ein Umschwung vollzogen. Der Fokus verschiebt sich weg von überteuerten KI-Highflyern hin zu soliden Qualitätswerten aus der zweiten Reihe.

Anleger, die jetzt clever agieren, setzen nicht auf das, was war, sondern auf das, was kommt. Unternehmen mit gesunder Bilanz, unterschätztem Potenzial und begrenztem Abwärtsrisiko könnten 2026 zu den großen Gewinnern zählen. Die Gefahr einer schärferen Korrektur bleibt real, gerade für passiv aufgestellte Investoren.

In unserem neuen Spezialreport stellen wir fünf Aktien vor, die genau jetzt das Potenzial für überdurchschnittliche Renditen bieten. Stark, günstig und bislang kaum im Fokus.

Jetzt kostenlosen Report herunterladen – bevor es andere tun!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.